Clinical Trial

Comparative Study of EnliTuo® Before and After Technology Change in Healthy Male Volunteers

Active, Not Recruiting Phase 1
View on ClinicalTrials.gov →
Summary
This study is a randomized, double-Blind, parallel-controlled, single-dose pharmacokinetic, safety, and immunogenicity comparative study of EnliTuo® before and after technology change in healthy male volunteers.
Protocol Amendment History 1 amendment
This ClinicalTrials.gov record has been amended once since 2025-11-17.
Status change: Recruiting → Active, Not Recruiting 2026-05-05
Trial Details
NCT Number NCT07246291
Lead Sponsor Taizhou Mabtech Pharmaceutical Co.,Ltd
Conditions Healthy Adult Male
Enrollment 86 participants
Start Date 2025-11-11
Primary Completion 2026-04-16 (estimated)
Study Completion 2026-05-13 (estimated)
Updated on ClinicalTrials.gov 2026-05-07